Briefly, tell us about your background and career up to this point?
I come from India, where my passion for science was sparked the moment I discovered that DNA could be extracted and edited. A revelation that opened my mind to the endless possibilities for solving real-world challenges. This fascination led me to pursue a bachelor’s degree in biotechnology at Fergusson College, where I gained hands-on experience in genetic engineering, molecular biology, and cell culture. Each experiment and discovery deepened my desire to push the boundaries of this field.
Determined to further my knowledge and achieve a childhood dream, I embarked on a master’s journey in the UK, earning an MSc in Biotechnology, Bioprocessing, and Business Management from the University of Warwick. My path then took me to Charles River Laboratories, where I contributed to groundbreaking work in cell and gene therapy research, focusing on critical starting materials for these life-changing treatments.
Now, at King’s College London, I am part of the Gene Therapy and Vector Facility, advancing innovations in adeno-associated viral (AAV) vector platforms for gene therapy. With each step, my commitment to scientific exploration and meaningful impact continues to grow, driven by a belief that the potential of biotechnology is only beginning to unfold.
What is a typical day like for you?
My current role focuses on establishing a new facility, which includes qualifying and validating equipment. It’s a dynamic blend of desk work and hands-on lab activities. On office days, I prepare documentation for experiments and processes, ensuring everything is ready for execution. On lab days, I carry out experiments and meticulously document the results, all while adhering to GMP compliance standards.
Do you have any current projects that you’d like to tell us about?
Currently, the major project I am working on is the establishment of an AAV gene delivery platform. In gene therapy, an effective delivery system is crucial for introducing new DNA into target cells, and adeno-associated virus (AAV) has emerged as a leading tool for this purpose. My primary responsibility lies in the downstream processing phase, where I collaborate closely with the Process Development (PD) and Manufacturing Science and Technology (MSAT) teams on technology transfer. Additionally, I am involved in drafting Batch Manufacturing Records (BMR) and other critical documentation to ensure process standardization and compliance.
Where do you see yourself in five years’ time?
In five years, I see myself continuing to contribute to the field of biotechnology while pursuing a PhD to deepen my knowledge and enhance my expertise. This will allow me to drive innovation, develop impactful solutions, and advance my career in gene and cell therapy research.
What do you do with your time outside academia/work?
Outside of work, I enjoy traveling, exploring new places, and capturing moments through photography. Additionally, I take pride in helping others by providing career guidance to those who reach out to me.
What is your favourite thing about working at King’s?
My favourite thing about working at King’s is the supportive environment that encourages independence while providing ample opportunities to learn and develop new skills.
QUICK-FIRE:
Favourite season: Autumn
Favourite cuisine: Mexican
Coffee order: Latte
Three words your friends would use to describe you: Determined, empathetic, humble.